Astley Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Astley Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2011-11-24 Coimbatore, Tamil Nadu Active Unlisted Active Non-Compliant
Share
Connect MCP
AL Astley Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Astley Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
56/100
Trust Score
Moderate

Astley Life Sciences Private Limited is assessed as Moderate with a Trust Score of 56/100. Astley Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Trading sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 06 Aug 2026 from the latest processed filings. Astley Life Sciences Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
56/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
25/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 25/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
  • Flagged by authority: MCA.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
SRIRAMULU SRINIVASAN 01234567 Director 01/04/2018 6 yrs Approved
SRIRAMULU HEMALATHA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • SRIRAMULU SRINIVASAN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: SRIRAMULU SRINIVASAN (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 65
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 14+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Compliance score is weak (25/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence46/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view60/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 9 events
30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
28 Sep 2013
Director ceased
SRIRAMULU HEMALATHA
31 Aug 2013
Director ceased
ANNAMALAI KRISHNAN
28 Aug 2013
Director appointed
SRIRAMULU HEMALATHA (Director)
Director ceased
PRADEEP BALAKRISHNAN
10 Dec 2011
Director ceased
SRIRAMULU SRINIVASAN
05 Dec 2011
Director appointed
SRIRAMULU SRINIVASAN (Managing Director)
24 Nov 2011
Incorporated
Registered with Roc Coimbatore
10

Key Observations

Auto-generated from the data above
Revenue declined 24% over the last 2 financial year(s).
Net profit margin moved from 0.86 to 61%.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Iora Diamonds Private Limited U36911MH2007PTC172198 Mumbai, Maharashtra, India
Periwal Motors Private Limited U50101RJ2004PTC019851 Bikaner, Rajasthan, India
Aryadeep Complex Private Limited U45400CT2012PTC001977 Champa, Chattisgarh, India
Jan Chetna Marketing Network Private Limited U51909DL2009PTC196351 Delhi, Delhi, India
Wirerope & Slings Private Limited U28910GJ2015PTC083473 Ahmedabad, Gujarat, India
Ptc Marketing Private Limited U74999PB1995PTC015938 Ludhiana, Punjab, India
Gannet Vanijya Limited U74999WB2010PLC154489 Kolkata, West Bengal, India
Saw Energy Systems Trading Company Private Limited U40106MH2008PTC184058 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Astley Life Sciences Private Limited before audits and certifications: compliance score 25/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Astley Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Astley Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 56/100, distress signals and MSME payment-delay disclosures - know whether Astley Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Astley Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Astley Life Sciences Private Limited an active company?

Astley Life Sciences Private Limited has MCA status “Active” with a compliance score of 25/100 (Caution Indicated).

Is Astley Life Sciences Private Limited financially healthy?

Astley Life Sciences Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Astley Life Sciences Private Limited?

Its overall Trust Score is 56/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Astley Life Sciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Astley Life Sciences Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Astley Life Sciences Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 25/100 (Caution Indicated).

Is it risky to lend to Astley Life Sciences Private Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.